Cardior Pharmaceuticals: Cardior Welcomes Dr. Orly Vardeny a

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins

Related Keywords

United States , American , Russell Greig , Claudia Ulbrich , Kostenloser Wertpapierhandel , Eva Mulder , Claudia Ulbrich Eva , University Of Minnesota Medical School , University Of Minnesota , Cardior Pharmaceuticals Gmb , Trophic Communications , Cardior Pharmaceuticals , Orly Vardeny , Minnesota Medical School , Associate Editor , Heart Failure , American College , Heart Failure Society , America Guidelines , Claudia Ulbrich Eva Stra , Pharmaceuticals Gmbh , Cardior , Pharmaceuticals , Elcomes , Orly , Ardeny , Permanent , Guest , Board ,